|300,717 Patients Studied||515 Studies (View)|
Definition: Bicalutamide (marketed as Casodex, Cosudex, Calutide, Kalumid) is an oral non-steroidal anti-androgen used in the treatment of prostate cancer and hirsutism. It was first launched in 1995 as a combination treatment (with surgical or medical castration) for advanced prostate cancer and subsequently launched as monotherapy for the treatment of earlier stages of the disease. Bicalutamide is marketed by AstraZeneca with the brand names Casodex and Cosudex. (SOURCE: Wikipedia)
Most Researched Conditions
What other conditions have been studied?
What peer treatments do patients prefer?
PositiveBased on 84 web discussions, patients on Bicalutamide felt 10% more positively about Bicalutamide relative to peer treatments.
What does the FDA say about side effects?
Most Discussed Conditions
What conditions are patients discussing?
Most Discussed Symptoms
What symptoms are patients discussing?
What treatments have patients discontinued using?
Top Discussion Forums
What are the most popular websites?
Which institutions publish the strongest evidence?